BIT’s 2nd Annual International Congress of Biotherapy (ICB), 10th Anniversary of International Congress of Antibody (ICA) and 11th Anniversary of World Congress of Vaccines (WCV) is organized by BIT Congress Inc. (BIT Group Global Ltd.) and will be held during Mar 23 - 25, 2018 at DoubleTree by Hilton Hotel Washington DC - Crystal City, Arlington, Virginia, United States of America.
Conference Description :
The theme of this conference is "The Fourth Revolutionary Wave of Pharm Industry".
This conference aims to be the most comprehensive antibody congress where discoveries meet opportunities. This event will once again bring together thought leaders from pharmaceutical, biotech companies, consultants, regulatory authorities and academics, including well-known industry experts innovative technology developers and expert scientists, to present the latest research results, ideas, developments, applications and business prospects in Biotherapy, Antibody and Vaccines.
This conference will include plenary sessions, panel discussions, and paper presentations. Roundtable discussions, matchmaking, exhibitions, field trip and tech-tour will also help foster a fruitful exchange of information and ideas.
Conference Highlights :
• Designing 100+ Sessions of Scientific Forums, Symposia, Roundtables, Dialogs, Workshops, And Training Courses Covering Top Trends and Advances in Biotherapeutic R & D
• Inviting Worldwide Distinguished Experts, Investors, And Decision Makers in the Areas of Protein R & D for the Grand Thought Collision from 50+ Countries
• Shooting for 500+ Oral Presentations and Hot Paper Briefing in Whole Spectrum of Breakthroughs in Biopharmaceutical R & D from both Industry and Academia
• Gathering 50+ Exhibitors in Cutting-Edge Technologies and Novel Bioproducts
• Bring in up to 1000 Distinguished Participants All Together in Fields of Immunotherapy, such as Antibody and Vaccines, Gene Therapy, Cell Therapy and protein therapeutics to Knowledge Mall, Washington D. C.
• Bringing in 10+ Professional Media Supporters
• Scheduling 4+ Sessions of Business & Career Development, And Talent Search
• Multi-Zones of Poster Show and Exhibitions of New Finding, New IP, New Tech and New Products
• 2-3 Interactive Events to Enhance the Professional Network and Matchmaking
• One Annual Report Release/Peers Review on Current Trend, Economic Value, Scientific Breakthroughs and Future Directions on Biotherapeutic R & D
Additional details will be posted as soon as they are available.